Can High-Sensitivity Troponins Predict Future Hypertension? A Systematic Literature Review

References

• Jagodzinski A, Neumann JT, Ojeda F, et al. Cardiovascular biomarkers in hypertensive patients with medical treatment - results from the randomized TEAMSTA Protect I Trial. Clin Chem. 2017;63(12):1877–1885.
   PubMed Web of Science ®Google Scholar
• Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013;31(7):1281–1357.
   PubMed Web of Science ®Google Scholar
• Hansen TW, Thijs L, Li Y, et al. Prognostic value of reading-to-reading blood pressure variability over 24 h in 8938 subjects from 11 populations. Hypertension. 2010;55(4):1049–1057.
   PubMed Web of Science ®Google Scholar
• Asayama K, Satoh M, Kikuya M. Diurnal blood pressure changes. Hypertens Res. 2018;41(9):669–678.
   PubMed Web of Science ®Google Scholar
• Pickering TG. The clinical significance of diurnal blood pressure variations. Dippers and nondippers. Circulation. 1990;81(2):700–702.
   PubMed Web of Science ®Google Scholar
• Honda Y, Watanabe T, Tamura H, et al. Presence of myocardial damage predicts future development of hypertension in a normotensive japanese general population: the Yamagata (Takahata) study. Am J Hypertens. 2018;31(5):549–556.
   PubMed Web of Science ®Google Scholar
• Wu AHB, Christenson RH, Greene DN, et al. Clinical laboratory practice recommendations for the use of cardiac troponin in acute coronary syndrome: Expert opinion from the Academy of the American Association for Clinical Chemistry and the Task Force on Clinical Applications of Cardiac Bio-Markers of the International Federation of Clinical Chemistry and Laboratory Medicine. Clin Chem. 2018;64:645–655.
   PubMed Web of Science ®Google Scholar
• Boeddinghaus J, Reichlin T, Nestelberger T, et al. Early diagnosis of acute myocardial infarction in patients with mild elevations of cardiac troponin. Clin Res Cardiol. 2017;106(6):457–467.
   PubMed Web of Science ®Google Scholar
• Holzmann MJ. Clinical implications of high-sensitivity cardiac troponins. J Intern Med. 2018;284(1):50–60.
   PubMed Web of Science ®Google Scholar
• Thygesen K, Mair J, Katus H, et al. Recommendations for the use of cardiac troponin measurement in acute cardiac care. Eur Heart J. 2010;31(18):2197–2204.
   PubMed Web of Science ®Google Scholar
• Stewart LA, Clarke M, Rovers M, et al. Preferred reporting items for systematic review and Meta-Analyses of individual participant data: the PRISMA-IPD statement. JAMA. 2015;313(16):1657–1665.
   PubMed Web of Science ®Google Scholar
• O’Connor D, Green S, Higgins J. Chapter 5: Defining the review question and developing criteria for including studies [updated February 2008]. In: Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions version 5.0.0. London (UK): The Cochrane Collaboration; 2008.
   Google Scholar
• Sato Y, Yamamoto E, Sawa T, et al. High-sensitivity cardiac troponin T in essential hypertension. J Cardiol. 2011;58(3):226–231.
   PubMed Web of Science ®Google Scholar
• Sugiura T, Dohi Y, Takase H, et al. Differential effects of brachial and central blood pressures on circulating levels of high-sensitivity cardiac troponin I in the general population. Atherosclerosis. 2018;269:185–191.
   PubMed Web of Science ®Google Scholar
• Everett BM, Zeller T, Glynn RJ, et al. High-sensitivity cardiac troponin I and B-type natriuretic peptide as predictors of vascular events in primary prevention: impact of statin therapy. Circulation. 2015;131(21):1851–1860.
   PubMed Web of Science ®Google Scholar
• Aeschbacher S, Schoen T, Bossard M, et al. Relationship between high-sensitivity cardiac troponin I and blood pressure among young and healthy adults. Am J Hypertens. 2015;28(6):789–796.
   PubMed Web of Science ®Google Scholar
• Askin L, Yesiltepe Y. High-Sensitivity cardiac troponin T levels in prehypertensive patients. Clin Exp Hypertens. 2018;40(4):332–336.
   PubMed Web of Science ®Google Scholar
• Griffiths ME, Malan L, Delport R, et al. Troponin T release is associated with silent myocardial ischaemia in black men: the SABPA study. Eur J Prev Cardiolog. 2017;24(9):942–950.
   PubMed Web of Science ®Google Scholar
• Rubin J, Matsushita K, Lazo M, et al. Determinants of minimal elevation in high-sensitivity cardiac troponin T in the general population. Clin Biochem. 2016;49(9):657–662.
   PubMed Web of Science ®Google Scholar
• McEvoy JW, Chen Y, Nambi V, et al. High-sensitivity cardiac Troponin T and risk of hypertension. Circulation. 2015;132(9):825–833.
   PubMed Web of Science ®Google Scholar
• McEvoy JW, Lazo M, Chen Y, et al. Patterns and determinants of temporal change in high-sensitivity cardiac troponin-T: the atherosclerosis risk in communities cohort study. Int J Cardiol. 2015;187:651–657.
   PubMed Web of Science ®Google Scholar
• Miao DM, Zhang LP, Yu HP, et al. Serum levels of high-sensitivity troponin T: a novel marker for left ventricular remodeling and performance in hypertensive subjects. Genet Mol Res. 2014;13(3):5143–5153.
   PubMed Web of Science ®Google Scholar
• Askin L, Tasolar H, Aksu U, et al. Discerning the relationship between left ventricular geometry, high-sensitivity troponin T, and nondipper hypertension. Blood Press Monit. 2018;23(1):12–18.
   PubMed Web of Science ®Google Scholar
• Cayli M, Gur M, Elbasan Z, et al. High-sensitivity cardiac troponin T predicts nondipper hypertension in newly diagnosed hypertensive patients. J Clin Hypertens. 2013;15:731–736.
   Web of Science ®Google Scholar
• Gore MO, Seliger SL, Defilippi CR, et al. Age- and sex-dependent upper reference limits for the high-sensitivity cardiac troponin T assay. J Am Coll Cardiol. 2014;63(14):1441–1448.
   PubMed Web of Science ®Google Scholar
• Eggers KM, Lindahl B. Impact of sex on cardiac troponin concentrations- a critical appraisal. Clin Chem. 2017;63(9):1457–1464.
   PubMed Web of Science ®Google Scholar
• Collinson PO, Heung YM, Gaze D, et al. Influence of population selection on the 99th percentile reference value for cardiac troponin assays. Clin Chem. 2012;58(1):219–225.
   PubMed Web of Science ®Google Scholar
• Skadberg Ø, Sandberg S, Røraas T, et al. The variation in high sensitive cardiac troponin concentration during haemodialysis treatment is not similar to the biological variation observed in stable end stage renal disease patients. Scand J Clin Lab Invest. 2016;76(8):645–652.
   PubMed Web of Science ®Google Scholar
• Shave R, Ross P, Low D, et al. Cardiac troponin I is released following high-intensity short-duration exercise in healthy humans. Int J Cardiol. 2010;145(2):337–339.
   PubMed Web of Science ®Google Scholar
• Tjora S, Gjestland H, Mordal S, et al. Troponin rise in healthy subjects during exercise test. Int J Cardiol. 2011;151(3):375–376.
   PubMed Web of Science ®Google Scholar
• [cited 2018 Sept 13] Available from https://www.westgard.com/biodatabase1.htm.
   Google Scholar
• Libby P, Ridker PM. Inflammation and atherosclerosis: role of C-reactive protein in risk assessment. Am J Med. 2004;116(Suppl 6A):9S–16S.
   PubMed Web of Science ®Google Scholar
• Dunn FG. Hypertension and myocardial infarction. J Am Coll Cardiol. 1983;1(2):528–532.
   PubMed Web of Science ®Google Scholar
• Roos A, Bandstein N, Lundbäck M, et al. Stable high-sensitivity cardiac troponin T levels and outcomes in patients with chest pain. J Am Coll Cardiol. 2017;70(18):2226–2236.
   PubMed Web of Science ®Google Scholar
• Ridker PM, JUPITER Study Group. Rosuvastatin in the primary prevention of cardiovascular disease among patients with low levels of low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: rationale and design of the JUPITER trial. Circulation. 2003;108(19):2292–2297.
   PubMed Web of Science ®Google Scholar